Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1318407

GTEX

4dee21c7-200c-57c7-9a31-75849c9eb56d

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • MYOGENESIS+0.237
  • MYC_TARGETS_V2+0.162
  • DNA_REPAIR+0.151
  • KRAS_SIGNALING_DN+0.115
  • WNT_BETA_CATENIN_SIGNALING+0.085
  • MITOTIC_SPINDLE+0.028
  • SPERMATOGENESIS+0.022
  • APICAL_JUNCTION+0.017
  • P53_PATHWAY-0.044
  • HEME_METABOLISM-0.054

Top 10 suppressed

  • INTERFERON_ALPHA_RESPONSE-0.466
  • INFLAMMATORY_RESPONSE-0.460
  • INTERFERON_GAMMA_RESPONSE-0.458
  • ALLOGRAFT_REJECTION-0.447
  • ANGIOGENESIS-0.443
  • TGF_BETA_SIGNALING-0.436
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.424
  • KRAS_SIGNALING_UP-0.418
  • COAGULATION-0.417
  • TNFA_SIGNALING_VIA_NFKB-0.394

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1499982
brain-umap@2
GTEX0.961
2SRR1415215
brain-umap@2
GTEX0.958
3SRR1440119
brain-umap@2
GTEX0.956
4SRR1471417
brain-umap@2
GTEX0.956
5SRR1464305
brain-umap@2
GTEX0.954
6SRR1489054
brain-umap@2
GTEX0.954
7SRR1359367
brain-umap@2
GTEX0.953
8SRR1327811
brain-umap@2
GTEX0.952
9SRR1417981
brain-umap@2
GTEX0.951
10SRR1398839
brain-umap@2
GTEX0.951

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 8 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
MYOGENESIS0.237Inavolisib— uncovered
MYC_TARGETS_V20.162Idelalisib— uncovered
DNA_REPAIR0.151Idelalisib— uncovered
KRAS_SIGNALING_DN0.115Remibrutinib— uncovered
WNT_BETA_CATENIN_SIGNALING0.085Inavolisib— uncovered
MITOTIC_SPINDLE0.028Inavolisib— uncovered
SPERMATOGENESIS0.022Inavolisib— uncovered
APICAL_JUNCTION0.017Inavolisib— uncovered